Members

MYELOMAX

MYELOMAX

Our mission is to assist our clients in the evaluation of drug efficiency, mechanism, identification of biomarkers in Multiple Myeloma, a cancer that allows introduction of new types of therapeutic molecules for treatment of cancers (proteasome inhibitors, immunomodulators)

Take contact

Type de structure :
Address: IRT 1
8, quai Moncousu
BP 70721
44007 Nantes Cedex 01